This mechanistic paradigm not only deepens our understanding of circRNA-driven carcinogenesis but also positions the circPPFIA2-ETS1 axis as a promising therapeutic target for disrupting oncogenic signaling networks in advanced PCa. This evidence concerns the gene ETS1 and posterior cortical atrophy.